4.8 Article

PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

Journal

NATURE CELL BIOLOGY
Volume 7, Issue 9, Pages 870-U16

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1288

Keywords

-

Categories

Funding

  1. NCI NIH HHS [R01 CA095287, P01 CA72006, R01 CA099948, R01 CA95287, R01 CA095287-05, R01 CA109390-01, P01 CA072006-07, R01 CA99948, R01 CA109390, P01 CA072006] Funding Source: Medline
  2. NHLBI NIH HHS [T32 HL007731, 5T32HL007731] Funding Source: Medline

Ask authors/readers for more resources

The microvasculature consists of endothelial cells and their surrounding pericytes. Few studies on the regulatory mechanisms of tumour angiogenesis have focused on pericytes. Here we report the identification of tumour- derived PDGFR beta(+) ( platelet- derived growth factor receptor beta) progenitor perivascular cells ( PPCs) that have the ability to differentiate into pericytes and regulate vessel stability and vascular survival in tumours. A subset of PDGFR beta(+) PPCs is recruited from bone marrow to perivascular sites in tumours. Specific inhibition of PDGFR beta signalling eliminates PDGFR beta(+) PPCs and mature pericytes around tumour vessels, leading to vascular hyperdilation and endothelial cell apoptosis in pancreatic islet tumours of transgenic Rip1Tag2 mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available